The role of polyunsaturated fatty acid metabolism in overweight and obese children and adolescents
Abstract
The problem of obesity is currently being widely discussed by various specialists. The literature dealing with this problem places a considerable emphasis on investigations of lipid metabolism disorders that occupy a prominent place in the genesis of cardiovascular diseases in the populations of most countries. The special role of long chain polyunsaturated fatty acids that are major functional components of brain membrane structure phospholipids, retinal photoreceptors is emphasized. Pediatricians pay great attention to the nutrition of infants, by adjusting adapted milk-based formulas for their adequate growth and development. At the same time, no consideration is given to the possibility of correcting obesity-associated problems with appropriate adapted milk-based formulas in older infants. However, dietary recommendations for older infants with obesity and overweight should be developed not only in the context of optimization of a qualitative and quantitative diet that ensures the needs of the growing organism at the present moment, but should take into account the prevention of cardiovascular diseases and other complications of obesity in the future.
About the Authors
A. A. Glazyrina
Morozov City Children's Clinical Hospital
Russian Federation
Russian Federation
M. Yu. Shcherbakova
Research Institute of Nutrition, Russian Academy of Medical Sciences
Russian Federation
Russian Federation
S. N. Denisova
N.I. Pirogov Russian National Research Medical University
Russian Federation
Russian Federation
I. E. Koltunov
Morozov City Children's Clinical Hospital
Russian Federation
Russian Federation
D. Yu. Ovsyannikov
Peoples' Friendship University of Russia, Moscow
Russian Federation
Russian Federation
References
1. Бюллетень Всемирной организации здравоохранения 2013; 91: 549—550. doi:http://dx.doi.org/10.2471/ BLT. 13.020813. (Bulletin of the World Organization ofhealthcare 2013; 91: 549-550. doi:http://dx.doi. org/10.2471/BLT.13.020813.)
2. Щербакова М.Ю., Порядина Г.И., Ковалева Е.А. Ожирение у детей — данные амбулаторного обследования. Лечащий врач 2010; 9: 80—84. (Shcherbakova M.Y., Porjadina G.I., Kovaleva E.A. Obesity in children — data outpatient department. Lechashhij vrach 2010; 9: 80—84.)
3. Shibli R., Rubin L., Akons H. et al. Morbidity of overweight (>85th percentile) in the first 2 years of life. Pediatrics 2008; 122: 267-272.
4. Картелишев A.B. Вопросы ранней диагностики предрасположенности детей к конституционально-экзогенному ожирению. Педиатрия 2006; 4: 7—11. (Kartelishev A.V. Issues of early diagnosis of predisposition to children constitutional — exogenous obesity. Pediatrija2006; 4: 7—11.)
5. Сорвачева Т.Н., Петеркова В.А., Титова Л.Н. И др. Ожирение у подростков. Лечащий врач 2006; 2: 50-54. (Sorvacheva T.N., Peterkova V.A., Titova L.N. Et al. Obesity in adolescents. Lechashhij vrach 2006; 2: 50—54.)
6. растущего организма в настоящий момент, но и учитывать профилактику сердечно-сосудистых заболеваний и других осложнений ожирения в будущем.
7. Redesell S., Atkinson P., Nathan D. et al. Preventing of childhood obesity during infancy in UK primary care: a mixed-methods study of HCP's knowledge, beliefs and practice. BMC Family Practice. 2011; 12: 54—79.
8. БыстроваАА., Рюмина И.А., Степанова В.Л. Особенности липидного спектра крови у больных сахарным диабетом типа 2. Тезисы Межрегиональной научно-практической конференции «Актуальные проблемы кардиологии» (5—6 июня 2008 г., Томск). Томск, 2008; 109. (Bystrova A.A., Rjumina LA, Stepanova V.L. Features lipid profile in patients with type 2 diabetes. Tezisy Mezhregional'noj nauchno-prakticheskoj konferencii «Actual problems of cardiology» (5—6 ijunja 2008 g., Tomsk). Tomsk, 2008; 109.
9. Нечаев А.П. Органическая химия. М: Высшая школа 1988; 319. (Nechaev A.P. Organic chemistry. Moscow: Vysshajashkola 1988; 319.)
10. Локтев СМ. Высшие жирные кислоты. М: Наука 1964; 3—17; 56—98. (Loktev S.M. Higher fatty acids. Moscow: Nauka 1964; 3—17: 56—98).
11. Racks P., RossmeislM., BryhnM., KopeckyJ. Cellular and molecular effects of n-3 polyunsaturated fatty acids on adipose tissue biology and metabolism. Clin Sci (Lond) 2009; 116:1:1—16.
12. Конь И.Я., Жилина Н.М., Вольфсон СБ., и др. Использование полиненасыщенных жирных кислот в питании здоровых детей. Лечащий врач 2006; 1: 42—47. (Коп11.Ja., Shilina N.M., Vol'fson S.B. et al. Use of polyunsaturated fatty acids in the diet of healthy children. Lechashhij vrach 2006; 1: 42-47.)
13. Voss A., Reinhart M., Sankarappea S. et al. The metabolism of 7, 10, 13, 16, 19-docosapentaenoic acid to 4, 7, 10, 13, 16, 19-docosahexaenoic acid in rat liver is independent of4-desaturase. JBiol Chem 1991; 266: 19995—20000.
14. Farquhason J., Cockbum F., Patric W.A. Infant cerebral cortex phospholipid fatty-acid composition and diet. The Lancet 1992; 340: 810-813.
15. Шамшева Д.С., Лаврова Т.Е. Иммунотропная роль длин-ноцепочечных полиненасыщенных жирных кислот: возможности нутритивной поддержки. Педиатрия 2013; 2: 92—99. (Shamsheva D.S., Lavrova Т.Е. Immunotropic role of long chain polyunsaturated fatty acids: possible nutritional support. Pediatrija2013; 2: 92—99.)
16. Fauser J.K., Prisciandaro L.D., Cummins A.G., et al. Fatty acids as potential adjunctive colorectal chemotherapeutic agents. Cancer BiolTher 2011; 11: 8: 724—731.
17. Al-Taan O., Stephenson J.A., Spencer L. et al. Changes in plasma and erythrocyte omega-6 and omega-3 fatty acids in response to intravenous supply of omega-3 fatty acids in patients with hepatic colorectal metastases. Lipids Health Dis2013; 12: 64. doi: 10.1186/1476-511X-12-64.
18. Kuapers R.S., De Graaf D.G., Luxwolda M.F. et al. Saturated fat, carbohydrates and cardiovascular disease. Neth J Med 2011; 69: 9: 372-378.
19. Decsi Т., Kennedy К Sex-specific differences in essential fatty acid metabolism. Am J Clin Nutr 2011; 94: 6 Suppl: 1914S— 1919S.
20. Комарова О.Н., Жилина Н.М., Погомий TT.TT. и др. Роль лейкотриенов 4 и 5 в патогенезе бронхиальной астмы удетей. Педиатрия 2006; 1: 85: 5: 35-42. (Komarova O.N., Shilina N.M., Pogomij N.N. et al. The role of leukotrienes 4 and 5 in the pathogenesis of asthma in children. Pediatrija 2006; 1:85: 5: 35-42.)
21. Saini-Chohan H.K., MitchellR.W., VazF.M. etal. Delineating the role of alterations in lip id metabolism to the pathogenesis of inherited skeletal and cardiac muscle disorders: Thematic Review Series: Genetics of Human Lipid Diseases. J Lipid Res 2012; 53: 1:4-27.
22. Тубанова Е.В. Эффективность применения омега-3 жирных кислот и растительно-витаминного комплекса "Марина" при хронической гастроэнтерологической патологии у детей: Автореф. дис. ... канд. мед. наук. М 2004; 24. (Gubanova E.V. Efficacy of omega-3 fatty acids and plant-vitamin complex "Marina" in chronic gastroenterological diseases in children: Avtoref. dis.... kand. med. nauk. Moscow 2004; 24)
23. Harris W.S., Connor W.E., Illingworth D.R. et al. Effects offish oil on VLDLtriglyceridekinetics inhumans. JLipidRes 1990; 31:9:1549-1558.
24. Appel L.J., Miller E.R. 3rd, Seidler A.J. et al. Does supplementation of diet with 'fish oil1 reduce blood pressure? A meta-analysis of controlled clinical trials. Arch Intern Med 1993; 153: 12: 1429-1438.
25. Morris M.C., Taylor J.O., Stampfer M.J. et al. The effect of fish oil on blood pressure in mild hypertensive subjects:
26. a randomized crossover trial. Am J Clin Nutr 1993; 57: 1: 59-64.
27. Abeywardena M.Y., Patten G.S. Role of u)3 long-chain polyunsaturated fatty acids in reducing cardio-metabolic risk factors. Endocr Metab Immune Disord Drug Targets 2011; 11: 3: 232-246.
28. Nettleton J.A., Katz, R. w-3 long-chain polyunsaturated fatty acids in type 2 diabetes: a review. Am Diet Assoc 2005; 105: 3: 428-440.
29. Tudwig T, Worsch S., Heikenwalder M. et al. Metabolic and immunomodulatory effects of n-3 fatty acids are different in mesenteric and epididymal adipose tissue of diet-induced obese mice. Am J Physiol Endocrinol Metab 2013; 304: E1140-E1156.
30. Itariu B.K., Zeyda M., Hochbrugger E.E. et al. Long-chain u)-3 PUFAs reduce adipose tissue and systemic inflammation in severely obese nondiabetic patients: a randomized controlled trial. Am J Physiol Endocrinol Metab 2013; 304: 11: E1140—1156.
31. Bjermo ТТ., Iggman D., Kullberg J. et al. Effects of uj-6 PUFAs compared with SFAs on liver fat, lipoproteins, and inflammation in abdominal obesity: a randomized controlled trial. Am J Clin Nutr 2012; 96: 5: 1137-1149.
32. Corl B.A., Mat hews Oliver S.A., Tin X. et al. Conjugated linoleic acid reduces body fat accretion and lipogenic gene expression in neonatal pigs fed low- or high -fat formulas. J Nutr 2008; 138: 3: 449-454.
33. Kennedy M.J., Jellerson K.D., Snow M.Z. et al. Challenges in the pharmacologic management of obesity and secondary dyslipidemia in children and adolescents. Paediatr Drugs 2013; 15: 5: 335-342.
34. Eympoea CA. От эпидемии ожирения к эпидемии сахарного диабета. Consiliummedical2003; 5: 9:23—29. (Butrova S.A. From the obesity epidemic of diabetes. Consilium medical 2003; 5: 9: 23-29.)
35. Бирюкова Е.В., Маркина ТТ.В. Елюкофаж — настоящее и будущее в фармакотерапии метаболического синдрома. Эффективная фармакотерапия в эндокринологии 2007; 3: 12—17. (Birjukova E.V., Markina N.V. Glucophage - present and future pharmacotherapy of metabolic syndrome. Jeffektivnaja farmakoterapija v jendokrinologii2007; 3: 12—17.)
36. IITee S., Shureiqil. 15-Lipoxygenase-l as atumorsuppressor gene in colon cancer: is the verdict in? Cancer Metastasis Rev 2011; 30: 3-4: 481-491.
37. Tchernof A., Despres J.P. Pathophysiology of human visceral obesity: an update. Physiol Rev 2013; 93: 1: 359—404.
38. Scattolin M.A., Tin J., Peruchi M.M. et al. Neurocutaneous melanosis: follow-up and literature review. J Neuroradiol 2011; 38: 5: 313-318.
39. Рунихин А.Ю. Современные подходы к лечению ожирения. Лечащий врач 2006; 2: 20—23. (Runihin AJu. Modern approaches to the treatment of obesity. Lechashhij vrach 2006; 2: 20-23.)
40. Жилина Н.М., Конь И.Я. Современные представления о физиологических и метаболических функциях полиненасыщенных жирных кислот. Вопр дет диетол 2004; 2: 6: 25—30. (Shilina N.M., Коп1 IJa. Modern ideas about the physiological and metabolic functions of polyunsaturated fatty acids. Voprosy detskoj dietologii 2004; 2: 6: 25—30.)
Review
For citations:
Glazyrina A.A., Shcherbakova M.Yu., Denisova S.N., Koltunov I.E., Ovsyannikov D.Yu. The role of polyunsaturated fatty acid metabolism in overweight and obese children and adolescents. Rossiyskiy Vestnik Perinatologii i Pediatrii (Russian Bulletin of Perinatology and Pediatrics). 2014;59(2):48-53. (In Russ.)
Views:
678
Email this article 